Vitamin D and Female Fertility — What Does the Largest Review of Studies Show?

It's hard today to find a fertility clinic where vitamin D level isn't on the standard panel of tests before starting an IVF procedure. Vitamin D supplements are marketed as part of IVF preparation almost as often as folic acid, and in the media and on patient forums there's a widespread belief that a sufficiently high 25(OH)D level clearly increases the chance of pregnancy. This belief has roots in real, though still largely hypothetical, biology.

The vitamin D receptor (VDR) is indeed found not only in bone and the immune system, but also in tissues of the female reproductive system — the endometrium, ovaries, and placenta. This gave rise to the hypothesis that vitamin D might affect embryo implantation, uterine lining receptivity, or egg quality. It's worth stressing, though, that the mere presence of a receptor in a given tissue is evidence of a possible effect, not evidence of its actual scale or clinical significance — a distinction that tends to get glossed over in supplement marketing.

The hypothesis was bolstered by earlier, individual observational studies showing a correlation between higher vitamin D levels and better IVF outcomes in the women studied. The problem is that observational studies can't distinguish cause from coincidence — women with higher vitamin D levels may also differ from the rest of the population in age, body weight, lifestyle, or the season the test was taken, and each of these factors independently affects IVF success. That's why the answer to whether vitamin D really helps had to be sought in a pooled analysis of all available data.

In 2020, Fertility and Sterility, one of the leading journals in reproductive medicine, published a systematic review with meta-analysis specifically designed to settle this question based on the totality of available evidence, rather than individual studies. The review protocol had been pre-registered in the PROSPERO database (No. CRD42019134258), a standard that raises the methodological credibility of this kind of work.

What makes this study especially valuable as a lesson in reading scientific evidence is exactly the turning point between the primary analysis and the sensitivity analysis. In the first, simple comparison of the data — precisely the kind that often ends up in popular headlines and supplement marketing materials — women with normal vitamin D levels really did fare better. Had the review stopped at that stage, the conclusion would have been simple and catchy: "higher vitamin D, higher chance of pregnancy."

An I² of 61% for both main outcomes (CPR and LBR/OPR) describes substantial heterogeneity among the studies included in the meta-analysis — in other words, the individual studies differed enough from one another that pooling their results into a single number calls for interpretive caution. That's one reason we rate this particular review, despite being the largest and most rigorous summary of the topic to date, as moderate-strength evidence rather than strong — the study design itself (systematic review with meta-analysis) usually ranks high in the evidence hierarchy, but the reversal of the result after sensitivity analysis and the high heterogeneity warrant extra caution in this specific case.

The phenomenon where smaller, individual observational studies show an effect while a large, rigorously conducted meta-analysis doesn't confirm it isn't rare in medicine — it's rather a recurring pattern, especially where the factor being studied (here, vitamin D level) correlates with many other variables that affect the outcome. Women with higher vitamin D levels in populations studied in the IVF context are often younger, have a lower BMI, lead a more active lifestyle, or were tested in summer, when natural skin synthesis is higher — and each of these factors on its own is linked to a better IVF prognosis independent of vitamin D itself.

A large meta-analysis, by pooling data from many studies with different population characteristics, partly averages out and dilutes the influence of such confounding factors — so its result, even though less dramatic in the media than a single positive study, is usually closer to the truth. This is exactly the reverse of how many popular, though unconfirmed, beliefs about supplements arise: a single, promising study makes headlines, while the later, less spectacular meta-analysis that corrects it remains known mainly within the specialist community.

The practical risk lies elsewhere: in excessive expectations and in the guilt that some patients feel when, despite supplementation and a "normal" vitamin D level, the procedure doesn't succeed. If a clinic or an advertisement suggests vitamin D is a significant factor in IVF success, failure is easily reinterpreted as one's own neglect — "I didn't supplement enough," "I should have started earlier." The rigorous data show that such an interpretation has no solid scientific grounding, and blaming oneself over vitamin D levels after a failed cycle is unjustified.

It's worth separating two different questions that easily blend into one in casual conversation about supplements: "is vitamin D important for health?" and "does vitamin D specifically improve IVF outcomes?" The answer to the first question remains affirmative and well documented — as we describe in more detail in our entry on vitamin D3, the evidence for its role in bone density and immune function is strong, and deficiencies in Poland during the autumn-winter period affect the vast majority of the population, including women trying to conceive.

This topic is a good example of how a popular health belief can outpace rigorous scientific evidence — not out of bad intent, but because early, promising data spreads faster than a later, more cautious correction. The biological hypothesis behind vitamin D's role in fertility is sensible and worth further research, but currently the largest available systematic review doesn't confirm its practical significance for IVF outcomes after a rigorous analysis of the data.